EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Comprehensive Evaluation of Predictive Significance of FABP4 for Long-term Clinical Outcomes After Ischemic Stroke

Youdan Tu, Pei Feng, Lulu Sun, Yanyu Zhu, Suyang Wu, Yanbo Peng, Yonghong Zhang, Tan Xu, Chongke Zhong, Guodong Xiao

Translational Stroke Research · 2026-04 · 17 (2)

DOI: 10.1007/s12975-026-01425-w ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Translational Stroke Research, online erschienen am 06.03.2026. Verfasst von Youdan Tu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital of Soochow University, No.1055, Sanxiang Road, Suzhou, 215004, Jiangsu Province, China. Hauptthemen laut MEDLINE: Fatty Acid-Binding Proteins, Ischemic Stroke, Brain Ischemia, Stroke. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University, Project of MOE Key Laboratory of Geriatric Diseases and Immunology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fatty acid-binding protein 4 (FABP4) has been reported to be involved in cerebral ischemia injury by modulating neurological function and inflammatory responses. This study aimed to investigate the association between plasma FABP4 levels and long-term, comprehensive clinical outcomes after acute ischemic stroke. Plasma FABP4 levels were measured in 3352 patients with acute ischemic stroke from the Chinese Acute Ischemic Stroke Antihypertensive Trial. Primary outcome was the composite of death and major disability (modified Rankin Scale score ≥ 3); secondary outcomes included major disability, all-cause mortality, stroke-specific mortality, and cardiovascular events. After 24-month follow-up, 790 patients experienced primary outcome, including 502 major disability and 288 all-cause mortality. Compared with the lowest tertile, the highest tertile of FABP4 was associated with primary outcome (odds ratio [OR] 1.60, 95% confidence interval [CI] 1.27-2.00), major disability (OR 1.40, 95% CI 1.09-1.82), all-cause mortality (hazard ratio [HR] 1.58, 95% CI 1.15-2.17), stroke-specific mortality (HR 1.68, 95% CI 1.17-2.40), and cardiovascular events (HR 1.35, 95% CI 1.02-1.80). Adding FABP4 to the basic model with conventional risk factors significantly improved risk reclassification for primary outcome (net reclassification improvement: 24.95%; integrated discrimination index: 0.75%). FABP4 was among the top five important predictors for primary outcome, ranking higher than N-terminal pro-brain natriuretic peptide and other biomarkers. Elevated plasma FABP4 levels were associated with increased risks of a variety of adverse outcomes after ischemic stroke at 24 months, suggesting that FABP4 could serve as a promising biomarker to improve risk stratification for long-term prognosis in ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acid-Binding ProteinsIschemic StrokeBrain IschemiaStrokeHumansMaleFemaleAgedBiomarkersMiddle AgedPrognosisPredictive Value of TestsFollow-Up Studies

Stichwörter der Autor:innen

biomarkercardiovascular eventsfatty acid-binding protein 4ischemic strokemortality

Substanzen

Fatty Acid-Binding ProteinsFABP4 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, The Second Affiliated Hospital of Soochow University, No.1055, Sanxiang Road, Suzhou, 215004, Jiangsu Province, China.
  • Department of Epidemiology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-communicable Diseases, MOE Key Laboratory of Geriatric Diseases and Immunology,…
  • Kunshan Maternity and Children's Health Care Hospital, Kunshan, China.
  • Department of Neurology, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei, China.
  • Department of Neurology, The Second Affiliated Hospital of Soochow University, No.1055, Sanxiang Road, Suzhou, 215004, Jiangsu Province, China. ckzhong@suda.edu.cn.
  • Department of Neurology, The Second Affiliated Hospital of Soochow University, No.1055, Sanxiang Road, Suzhou, 215004, Jiangsu Province, China. yarrowshaw@hotmail.com.

Förderung

  • National Natural Science Foundation of China
  • Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University
  • Project of MOE Key Laboratory of Geriatric Diseases and Immunology
  • Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions, China

Zitieren

APA

Tu, Y., Feng, P., Sun, L., Zhu, Y., Wu, S., Peng, Y., Zhang, Y., Xu, T., Zhong, C., & Xiao, G. (2026). Comprehensive Evaluation of Predictive Significance of FABP4 for Long-term Clinical Outcomes After Ischemic Stroke. Translational Stroke Research, 17(2). https://doi.org/10.1007/s12975-026-01425-w

Vancouver

Tu Y, Feng P, Sun L, Zhu Y, Wu S, Peng Y, et al. Comprehensive Evaluation of Predictive Significance of FABP4 for Long-term Clinical Outcomes After Ischemic Stroke. Translational Stroke Research. 2026;17(2). doi:10.1007/s12975-026-01425-w

BibTeX
@article{Tu2026,
  author = {Tu, Youdan and Feng, Pei and Sun, Lulu and Zhu, Yanyu and Wu, Suyang and Peng, Yanbo and Zhang, Yonghong and Xu, Tan and Zhong, Chongke and Xiao, Guodong},
  title = {Comprehensive Evaluation of Predictive Significance of FABP4 for Long-term Clinical Outcomes After Ischemic Stroke},
  journal = {Translational Stroke Research},
  year = {2026},
  volume = {17},
  number = {2},
  doi = {10.1007/s12975-026-01425-w}
}
Kostenlos starten →